乳腺细胞酸酶诱导核重塑和减少乳腺癌细胞的生长
Filip Pano1, Laura Bub1, Débora Parrine2
1Uppsala University, Department of Medical Biochemistry and Microbiology, Uppsala, Sweden.
Cell death discovery
|October 28, 2025
概括
乳腺细胞化酶通过改变细胞形态和调节增殖和亡来影响乳腺癌的生长. 这项研究揭示了三酶进入癌细胞,影响染色质和基因质的修饰,影响瘤的进展.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 乳腺细胞在乳腺癌中存在,但它们在瘤生长中的作用尚未完全理解.
- 作为一个关键的杆细胞媒介体的酸酶正在研究其对乳腺癌细胞的影响.
研究的目的:
- 阐明杆细胞合酶影响乳腺癌细胞生长的机制.
- 为了研究三酶对癌细胞形态,增殖和亡的影响.
主要方法:
- 分析乳腺癌细胞形态和生长.
- 研究癌细胞中酸酶的吸收和核定位.
- 评估对染色体组织,基因素-3切断和表观遗传标记的影响.
- 在PyMT和人类三阴性乳腺癌模型中的体内研究.
- ATAC-seq分析以确定染色质可访问性的变化.
主要成果:
- 酸酶通过抗增殖和亲亡作用影响乳腺癌细胞形态和生长.
- 酸酶被乳腺癌细胞内部化,并定位到核中,影响染色质组织和基因素-3.
- 乳腺瘤中乳腺细胞被激活,而三酶的存在与增殖清除区域相关.
- 酸酶改变了关键癌症相关基因的染色质可访问性.
结论:
- 乳腺细胞合酶在调节乳腺癌进展方面发挥着重要作用.
- 酸酶对染色质和表观遗传学的核作用为其对瘤生长的影响提供了一个新的机制.
- 向巨细胞合酶可能为乳腺癌提供一种新的治疗策略.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K


